Covance utilizes unrivaled, proprietary data and technology to improve clinical study outcomes.
Xcellerate® is a suite of data and technology enabling solutions designed to increase drug and medical device development efficiency, reduce timelines, improve compliance, and drive commercialization.
Months Faster vs. The Industry Oncology - Global - Phase I-IV
Faster vs. The Industry Oncology - Global - Phase I-IV
Fewer vs. The Industry Oncology - Global - Phase I-IV
Better vs. The Industry Cardiology - Global - Phase I-IV
As regulatory guidance and data collection in clinical trials has evolved, sponsors face pressure to balance quality, productivity and cost for risk management and monitoring. The industry has adopted risk-based quality management (RBQM), yet the methodology is inconsistent. There is no standard way to measure the impact of the different approaches to RBQM on the effectiveness of clinical trial management. Learn more about our approach to establishing and tracking metrics - including those that could apply across the industry - to measure the success of an RBQM approach.